Fennec Pharmaceuticals (FENC) vs Ocugen (OCGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Fennec Pharmaceuticals is the larger company by market cap ($363.3 million vs $339.1 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | FENC | OCGN |
|---|---|---|
| Share price | $10.36 | $1.00 |
| Market cap | $363.30M | $339.11M |
| 1-day change | +0.10% | -3.85% |
| YTD return | +34.55% | — |
| 1-year return | +9.28% | — |
| 5-year return | +12.73% | — |
| Forward P/E | 10.93 | — |
| EPS (TTM) | $-0.12 | $-0.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.25 | $2.73 |
| 52-week low | $5.65 | $0.97 |
| Distance from 52-week high | -21.81% | -63.30% |
| Average volume | 193.70K | 5.84M |
| Shares outstanding | 35.07M | 339.11M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
FENC vs OCGN FAQ
Which is bigger, Fennec Pharmaceuticals or Ocugen?
Fennec Pharmaceuticals (FENC) is larger, with a market capitalization of $363.30M compared with $339.11M for Ocugen (OCGN).
Are Fennec Pharmaceuticals and Ocugen in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.